Anavex Life Sciences
AVXL
#8577
Rank
NZ$0.46 B
Marketcap
NZ$5.06
Share price
-4.47%
Change (1 day)
-69.08%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): NZ-$0.79

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is NZ-$0.78. a decrease over its 2024 EPS that were of NZ-$0.88.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025NZ-$0.913.85%
2024NZ-$0.88-13.33%
2023NZ-$1.01-3.23%
2022NZ-$1.0514.81%
2021NZ-$0.9120%
2020NZ-$0.76-16.67%
2019NZ-$0.9138.46%
2018NZ-$0.6618.18%
2017NZ-$0.56-21.43%
2016NZ-$0.71-35.38%
2015NZ-$1.10-36.27%
2014NZ-$1.72112.5%
2013NZ-$0.81-58.62%
2012NZ-$1.96-0%
2011NZ-$1.96-29.27%
2010NZ-$2.7751.85%
2009NZ-$1.83-0%
2008NZ-$1.83237.5%
2007NZ-$0.54
2006N/A-100%
2005NZ-$0.06763499.97%
2004NZ-$0.01127

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$13.26-1,804.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$0.76-197.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$12.76 1,541.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$2.92 276.09%๐Ÿ‡บ๐Ÿ‡ธ USA